Axsome Therapeutics Share Price Today
(NASDAQ: AXSM)

Name: Axsome Therapeutics Share Price Today (NASDAQ: AXSM) - Axsome Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Axsome Therapeutics share price is $109.92 & ₹9,364.19 as on 30 Apr 2025, 2.30 'hrs' IST

$109.92

▲

2.68

(2.49%)

Market is closed - opens 7 PM, 30 Apr 2025

View live Axsome Therapeutics share price in Dollar and Rupees. Guide to invest in Axsome Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Axsome Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Axsome Therapeutics share price movements

Today's Low: $107.27
Today's High: $111.40
$109.92
2.42%
Downside
Day's Volatility :3.71%
Upside
1.33%
52 Weeks Low: $64.11
52 Weeks High: $139.13
$109.92
41.68%
Downside
52 Weeks Volatility :53.92%
Upside
20.99%

Axsome Therapeutics (AXSM) Returns

Period	Axsome Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	2.01%	-4.8%	0.0%
6 Months	19.89%	-6.6%	0.0%
1 Year	45.4%	-1.3%	0.0%
3 Years	215.07%	6.4%	-5.1%

Axsome Therapeutics (AXSM) Key Statistics

in dollars & INR

Previous Close	$107.24
Open	$107.615
Today's High	$111.4
Today's Low	$107.265
Market Capitalization	$5.2B
Today's Volume	$571.6K
52 Week High	$139.1299
52 Week Low	$64.11
Revenue TTM	$385.7M
EBITDA	$-244.5M
Earnings Per Share (EPS)	$-5.99
Profit Margin	-74.47%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-231.63%

How to invest in Axsome Therapeutics Stock (AXSM) from India?

It is very easy for Indian residents to invest directly in Axsome Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Axsome Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Axsome Therapeutics or AXSM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Axsome Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Axsome Therapeutics shares which would translate to 0.008 fractional shares of Axsome Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Axsome Therapeutics, in just a few clicks!

Returns in Axsome Therapeutics (AXSM) for Indian investors in Rupees

The Axsome Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Axsome Therapeutics investment value today

Current value as on today

₹1,51,090

Returns

₹51,090

(+51.09%)

Returns from Axsome Therapeutics Stock

₹49,024 (+49.02%)

Dollar Returns

₹2,066 (+2.07%)

Indian investors sentiment towards Axsome Therapeutics (AXSM)

-93%

Period: Mar 30, 2025 to Apr 29, 2025. Change in 30 Days versus previous period

Search interest for Axsome Therapeutics Stock from India on INDmoney has decreased by -93% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Axsome Therapeutics

RTW INVESTMENTS, LLC
8.31%
Vanguard Group Inc
8.00%
BlackRock Inc
7.25%
Fairmount Funds Management LLC
3.01%
Bvf Inc
2.85%
FMR Inc
2.05%

Analyst Recommendation on Axsome Therapeutics

Rating

Trend

Buy

90%Buy

9%Hold

0%Sell

Based on 22 Wall street analysts offering stock ratings for Axsome Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Axsome Therapeutics Stock (AXSM)

What analysts predicted

Upside of 61.35%

Target:

$177.35

Current:

$109.92

Insights on Axsome Therapeutics Stock (Ticker Symbol: AXSM)

Price Movement
In the last 3 years, AXSM stock has moved up by 237.8%
Increasing Revenue
Revenue is up for the last 7 quarters, 46.7M → 118.76M (in $), with an average increase of 14.3% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -64.60M → -74.91M (in $), with an average decrease of 16.0% per quarter
AXSM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 73.0% return, outperforming this stock by 27.5%
Price to Sales
ForAXSM every $1 of sales, investors are willing to pay $13.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.5 for every $1 of sales.

Axsome Therapeutics Technicals Summary

Sell

Neutral

Buy

Axsome Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Axsome Therapeutics (AXSM) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Axsome Therapeutics, Inc.	-8.04%	19.89%	45.4%	215.07%	18.99%
Regeneron Pharmaceuticals, Inc.	-3.5%	-33.68%	-31.29%	-6.14%	16.46%
Beone Medicines Ltd	-8.24%	21.23%	62.23%	49.96%	78.11%
Vertex Pharmaceuticals Incorporated	2.53%	4.63%	26.54%	89.75%	95.01%
Alnylam Pharmaceuticals, Inc.	-5.61%	-9.46%	77.05%	83.29%	97.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Axsome Therapeutics, Inc.	NA	NA	0.0	-3.47	-2.32	-0.27	NA	1.17
Regeneron Pharmaceuticals, Inc.	15.72	15.72	0.96	39.38	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.1	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.35	17.95	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.72	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Axsome Therapeutics, Inc.	Buy	$5.2B	18.99%	NA	-74.47%
Regeneron Pharmaceuticals, Inc.	Buy	$65.6B	16.46%	15.72	31.07%
Beone Medicines Ltd	NA	$29.1B	78.11%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$127.0B	95.01%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$32.6B	97.62%	NA	-12.37%

Axsome Therapeutics Dividend announcements

Axsome Therapeutics Earnings
Axsome Therapeutics’s price-to-earnings ratio stands at None

About Axsome Therapeutics

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT1A agonist indicated for the treatment of excessive daytime sleepiness in patients with narcolepsy or obstructive sleep apnea; and Symbravo (MoSEIC meloxicam rizatriptan), or AXS-07, a rapidly absorbed, multi-mechanistic, selective COX-2 inhibitor, and 5-HT1B/1D agonist indicated for the acute treatment of migraine with or without aura. It also develops AXS-05 (dextromethorphan-bupropion), an investigational N-methyl-D-aspartate receptor antagonist, which has completed Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation; AXS-12 (reboxetine), a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator, which has completed Phase III trial to treat narcolepsy; AXS-14 (esreboxetine), a selective and potent norepinephrine reuptake inhibitor that has completed Phase III trial for the treatment of fibromyalgia and other conditions; and Solriamfetol, a dopamine and norepinephrine reuptake inhibitor, which is in Phase III trial for treating attention deficit hyperactivity, major depressive, binge eating, and excessive sleepiness associated with shift work disorder. The company has a research collaboration agreement with Duke University for evaluating AXS-05 in a Phase 2 clinical trial in smoking cessation. Axsome Therapeutics, Inc. was incorporated in 2012 and is based in New York, New York.

Organization	Axsome Therapeutics
Employees	683
CEO	Dr. Herriot Tabuteau M.D.
Industry	Health Technology

Management People of Axsome Therapeutics

Name	Title
Dr. Herriot Tabuteau M.D.	Founder, Chairman, CEO & President
Mr. Mark L. Jacobson M.A.	Chief Operating Officer
Mr. Hunter Murdock Esq.	General Counsel & Secretary
Mr. Ari Maizel	Chief Commercial Officer

Important FAQs about investing in AXSM Stock from India :

What is Axsome Therapeutics share price today?

Axsome Therapeutics share price today stands at $109.92, Open: $107.62 ; Previous Close: $107.24 ; High: $111.40 ; Low: $107.27 ; 52 Week High: $139.13 ; 52 Week Low: $64.11.

The stock opens at $107.62, after a previous close of $107.24. The stock reached a daily high of $111.40 and a low of $107.27, with a 52-week high of $139.13 and a 52-week low of $64.11.

Can Indians buy Axsome Therapeutics shares?

Yes, Indians can invest in the Axsome Therapeutics (AXSM) from India.

With INDmoney, you can buy Axsome Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Axsome Therapeutics at zero transaction cost.

How can I buy Axsome Therapeutics shares from India?

It is very easy to buy Axsome Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Axsome Therapeutics (AXSM) be purchased?

Yes, you can buy fractional shares of Axsome Therapeutics with INDmoney app.

What are the documents required to start investing in Axsome Therapeutics stocks?

To start investing in Axsome Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.